NCT04670302 is a NA clinical trial of Tendon repair procedure in Supraspinatus Tear, sponsored by Dr. Soetomo General Hospital.

Who is sponsoring NCT04670302?

NCT04670302 is sponsored by Dr. Soetomo General Hospital.

What drugs are being tested in NCT04670302?

Interventions in NCT04670302: Tendon repair procedure, Tendon repair augmented with AAdMSC-HAM composite.

What condition does NCT04670302 study?

NCT04670302 studies Supraspinatus Tear.

Is NCT04670302 still recruiting?

NCT04670302 is currently status unknown. Last updated 17 December 2020.

Last reviewed 2020-12-17 · How we verify

NCT04670302

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Mesenchymal Stem Cells and Amniotic Membrane Composite for Supraspinatus Tendon Repair Augmentation

Status unknown NA Last updated 17 December 2020

What this trial tests

NA trial testing Tendon repair procedure in Supraspinatus Tear in 24 participants. Status unknown.

Timeline

17 October 2019

Primary endpoint
31 December 2021

31 December 2022

Quick facts

Lead sponsor	Dr. Soetomo General Hospital
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	non randomized
Design	parallel
Masking	single
Primary purpose	supportive care
Enrollment	24
Start date	17 October 2019
Primary completion	31 December 2021
Estimated completion	31 December 2022
Sites	1 location across Indonesia

Drugs / interventions tested

Tendon repair procedure
Tendon repair augmented with AAdMSC-HAM composite

Conditions studied

Supraspinatus Tear — all drugs for Supraspinatus Tear →

Sponsor

Dr. Soetomo General Hospital

Who can join

Adults 35 to 75, any sex, with Supraspinatus Tear. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This is a non-randomized clinical trial conducted in a single tertiary hospital which investigates the efficacy of allogeneic adipose-derived mesenchymal stem cells and human amniotic membrane (AAdMSC-HAM) composite for supraspinatus tendon repair augmentation

Publications & conference data

4 peer-reviewed publications reference this trial (live from Europe PMC):

Sources, Characteristics, and Therapeutic Applications of Mesenchymal Cells in Tissue Engineering.
Gonzalez-Vilchis RA, Piedra-Ramirez A, Patiño-Morales CC, Sanchez-Gomez C, et al · · 2022 · cited 19× · PMID 35092596 · DOI 10.1007/s13770-021-00417-1
Cell-based therapy in the treatment of musculoskeletal diseases.
Trapana J, Weinerman J, Lee D, Sedani A, et al · · 2024 · cited 18× · PMID 39226104 · DOI 10.1093/stcltm/szae049
Viewing Decellularized Amniotic Membrane Through the Lens of Coupled Scaffolding and Drug Delivery Systems in Regenerative Medicine.
Alibabaei-Omran F, Javanmehr N, Al-E-Ahmad A, Zabihi E, et al · · 2025 · PMID 40741540 · DOI 10.1155/term/8818058
Epigenetic mechanisms in stem cell therapies for achilles tendinopathy.
Yuan Z, Yao Z, Mao X, Gao X, et al · · 2025 · PMID 40181824 · DOI 10.3389/fcell.2025.1516250

Verify or expand the search:

Other recruiting trials for Supraspinatus Tear

Currently open trials in the same condition.

NCT05660031 — Treatment of the Biceps With Concomitant Supraspinatus Tears · NA · recruiting
NCT04444076 — Clinical Trial on the Effect of REGENETEN Bioinductive Implant in the Supraspinatus Tendon Repair · NA · active not recruiting

Other Dr. Soetomo General Hospital trials

Trials by the same sponsor.

NCT06935630 — Comparison of The Effect of 5-MTHF and Folic Acid Supplementation in Increasing Red Blood Cell Folate in Pregnant Women · NA · recruiting
NCT06259578 — UNAIR Inactivated COVID-19 Vaccine as Homologue Booster (Immunobridging Study) · EARLY_PHASE1 · unknown
NCT07328113 — Interleukin-6 and Thyroid Dysfunction in Hemodialysis Patients · completed
NCT06272253 — UNAIR Inactivated COVID-19 Vaccine INAVAC as Heterologue Booster (Immunobridging Study) in Adolescent Subjects · EARLY_PHASE1 · unknown
NCT06282692 — INAVAC Vaccine Phase III (Immunobridging Study) in Healthy Population Aged 12 to 17 Years Old · Phase 3 · unknown

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04670302 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Dr. Soetomo General Hospital
Last refreshed: 17 December 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04670302.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing